`A0 120 Rev. 08/10
`
`T0:
`
`Mail Stop 3
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. 9‘ I116 you are hereby advised that a court action has been
`filed in the U.S. District Court
`for the District of Delaware
`on the following
`
`I: Trademarks or
`
`[Z Patents.
`
`( E] the patent action involves 35 U.S.C. § 292.):
`
`DOCKET NO.
`
`PLAINTIFF
`
`
`
`
`DATE FILED
`1/26/2015
`
`U.S. DISTRICT COURT
`for the District of Delaware
`
`DEFENDANT
`
`
`
`
`SENJU PHARMACEUTICAL CO., LTD., et al.
`
`
`
`PADDOCK LABORATORIES, LLC, et al.
`
`
`
`
`
`%AJ%§;FD‘;*:}:EE£
`
`
`
`
`
`
`
`
`
`
`DATE INCLUDED
`
`In the aboVe—entitled case, the following patent(s)/ trademark(s) have been included:
`INCLUDED BY
`
`TR:g;]§4IEl;{%RNO
`
`HOLDER OF PATENT OR TRADEMARK
`
`D Amendment
`
`[I Answer
`
`l:I Cross Bill
`
`D Other Pleading
`
`——
`——
`——
`——
`
`In the above—entitled case, the following decision has been rendered or judgement issued:
`DECISION/JUDGEMENT
`
` (BY) DEPUTY CLERK
`
`DATE
`
`Copy 1—Upon initiation of action, mail this copy to Director Copy 3——Upon termination of action, mail this copy to Director
`Copy 2—Upon filing document adding patent(s), mail this copy to Director Copy 4—Case file copy
`
`P8991 of 145
`
`LUPIN EX 1046
`
`LUPIN EX 1046
`
`Page 1 of 145
`
`
`
`Case 1:14—cv-06893—JBS-KMW Document 4 Filed 11/03/14 Page 1 of 1 Page|D: 64
`
`
`
`
`
`OF AN
`FILING
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`
`
`
`Mail Stop 8
`
`Director ofthe U.S(.)1f’t2_:$nt and Trademark
`1, O Box 1450
`Alexandria, VA 22313-1450
`
`
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`filed in the U.S. District Court for the District of New Jersey on the following:
`Trademarks or X Patents. (
`the patent action involves 35 U.S.C. § 292.)
`
`
`
` U.S. DISTRICT COURT
`CAMDEN NJ
`
`DEFENDANT
`
`INNOPHARMA LICENSING, INC.
`
`
`
`DATE FILED
`DOCKET NO.
`l:l4—cv-06893-JBS-KMW 11/3/2014
`PLAINTIFF
`SENJU PHARMACEUTICAL CO., LTD.
`
`
`
`
`
`
`
`
`HOLDER OF PATENT OR TRADEMARK
`
`
`
`
`
`
`
`
`DATE INCLUDED
`
`n the above--entitled case the followin atent s / trademark s have been included:
`
`
`INCLUDED BY
`
`
`
`
`— I
`
`
`
`
` bJi\)*—‘
`
`PATENT OR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`HOLDER OF PATENT OR TRADEMARK
`
`Amendment
`
`Answer _ Cross Bill
`
`__ Other Pleading
`
`U1-5
`
`
`
`
`
`In the above-—entitled case the followin decision has been rendered or udement issued:
`DECISION/IUDGEMENT
`
` CLERK
`
`William T. Walsh
`
`(BY) DEPUTY CLERK
`s/ Nicholas Zotti
`
`DATE
`ll/3/2014
`
`
`
`
`
`Copy 1—Upon initiation of action, mail this copy to Director Copy 3~—Upon termination of action, mail this copy to Director
`Copy 2—Upon filing document adding patent(s), mail this copy to Director Copy 4—Case file copy
`
`Page 2 of 145
`
`Page 2 of 145
`
`
`
`TRADEMARK
`
`TO:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`filed in the U.S. District Court
`Eastern District Of North Carolina
`on the following
`
`I:l Trademarks or
`
`IZPatents.
`
`( E! the patent action involves 35 U.S.C. § 292.):
`
`DOCKET NO.
`U.S. DISTRICT COURT
`
`
`4:14-CV-141-BO
`Eastern District of North Carolina
`PLAINTIFF
`DEFENDANT
`
`Senju Pharmaceutical Co., Ltd., et al
`Metrics, |nc., et al
`
`DATE FILED
`8/8/2014
`
`
`
`
`
`
`
`——
`5 ——
`
`
`DATE INCLUDED
`
`INCLUDED BY
`
`In the above——entitled case, the following patent(s)/ trademark(s) have been included:
`
`
`
`MJCJ
`
`
`
`
`
`
`
`[I Answer
`
`El Cross Bill
`
`[:I Other Pleading
`
`l_—_I Amendment
`PATENT OR
`DATE OF PATENT
`TRADEMARK NO.
`OR TRADEMARK
`HOLDER OF PATENT OR TRADEMARK
`_——
`——
`——
`_—
`——
`
`In the above——entitled case, the following decision has been rendered or judgement issued:
`DECISION/JUDGEMENT
`
`(BY) DEPUTY CLERK
`
`Copy 1—Upon initiation of action, mail this copy to Director Copy 3—Upon termination of action, mail this copy to Director
`Copy 2——Upon filing document adding patent(s), mail this copy to Director Copy 4—Case file copy
`Page 3 of 145
`
`Page 3 of 145
`
`
`
`
`
`Case 1:14-cv—05144—JBS-KMW Document 3 Filed 08/15/14 Page 1 of 1 Page|D: 23
`
`O 120 Rev. 08/10
`
`Mail Stop 8
`
`Director ofthe U.Sbl;t2_::e:nt and Trademark
`P O Box 1450
`Alexandria, VA 22313-1450
`
`OF AN
`FILING
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`
`
`
`
`
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`filed in the U.S. District Court for the District of New Jersey on the following:
`Trademarks or X Patents. (
`the patent action involves 35 U.S.C. § 292.)
`
`
`
`
`
`
`
`
`DATE FILED
`DOCKET NO.
`l:l4—cv—05 144-JEI~KMW 8/15/2014
`PLAINTIFF
`SENJU PHARMACEUTICAL CO., LTD.
`
`U.S. DISTRICT COURT
`CAMDEN NJ
`DEFENDANT
`LUPIN, LTD.
`
`
`
`
`
`PATENT oR
`TRADEMARK NOV
`ism 121
`
`
`DATE OF PATENT
`HOLDER OF PATENT oR TRADEMARK
`OR TRADEMARK
`6/17/2014 KT
`—
`
`Amendment __ Answer
`
`Cross Bill
`
`DECISION/JUDGEMENT
`
`
`Copy 1--Upon initiation of action, mail this copy to Director Copy 3--Upon termination of action, mail this copy to Director
`Copy 2-—Upon filing document adding patent(s), mail this copy to Director Copy 4-Case file copy
`
`CLERK
`William T. Walsh
`
`
`
`Page 4 of 145
`
`
`
`(BY) DEPUTY CLERK
`s/ Nicholas Zotti
`
`DATE
`8/15/2014
`
`
`
`
`
`Page 4 of 145
`
`
`
`Case 1:14-cv-O4964—JBS Document 4 Filed 08/07/14 Page 1 of 1 PagelD: 52
`
`0120 Rev. 08/10
`
`Ma“ S‘°P 8
`Director of the U.S(.)lf’iatent and Trademark
`ice
`P.O. Box 1450
`Alexandria, VA 22313—1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`filed in the U.S. District Court for the District of New Jersey on the following:
`Trademarks or X Patents. (
`the patent action involves 35 U.S.C. § 292.)
`
`DOCKET NO.
`1:14—cv-04964*JBS
`
`DATE FILED
`8/7/2014
`
`PLAINTIFF
`SENJU PHARMACEUTICAL CO., LTD.
`
`U.S. DISTRICT COURT
`CAMDEN NJ
`
`DEFENDANT
`METRICS, INC.
`
`TT
`
`—
`INCLUDED BY
`In the above-—entitled case the followin atent s / trademark s have been included:
`DATE INCLUDED
`
`
`
`
`"# Amendment _ Answer _ Cross Bill _ Other Pleading
`
`PATENT OR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`HOLDER OF PATENT OR TRADEMARK
`
`-¥>-LrJl\)
`
`U1
`
`
`
`
`
`In the above-—entitled case the followin decision has been rendered or 'udement issued:
`DECISION/JUDGEMENT
`
`
`
`CLERK
`William T. Walsh
`
`(BY) DEPUTY CLERK
`3/ Brian D. Kemner
`
`DATE
`8/7/2014
`
`
`
`Copy 1--Upon initiation of action, mail this copy to Director Copy 3-—Upon termination of action, mail this copy to Director
`Copy 2—Upon filing document adding patent(s), mail this copy to Director Copy 4-—Case file copy
`
`Page 5 of 145
`
`Page 5 of 145
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`www.uspto.gov
`
`APPLICATION NO.
`
`14/165,976
`
`ISSUE DATE
`
`06/17/2014
`
`PATENT NO.
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`8754131
`
`2014-0075
`
`4523
`
`513
`
`7590
`
`05/28/2014
`
`WENDEROTH, LIND & PONACK, L.L.P.
`1030 15th Street, N.W.,
`Suite 400 East
`
`Washington, DC 20005-1503
`
`The projected patent number and issue date are specified above.
`
`ISSUE NOTIFICATION
`
`Determination of Patent Term Adjustment under 35 U.S.C. 154 (b)
`(application filed on or after May 29, 2000)
`
`The Patent Term Adjustment is 0 day(s). Any patent to issue from the above—identified application will include
`an indication of the adjustment on the front page.
`
`If a Continued Prosecution Application (CPA) was filed in the above—identified application, the filing date that
`determines Patent Term Adjustment is the filing date of the most recent CPA.
`
`Applicant will be able to obtain more detailed information by accessing the Patent Application Information
`Retrieval (PAIR) WEB site (http://pair.uspto. gov).
`
`Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the
`Office of Patent Legal Administration at (571)-272-7702. Questions relating to issue and publication fee
`payments should be directed to the Application Assistance Unit (AAU) of the Office of Data Management
`(ODM) at (571)-272-4200.
`
`APPLICANT(S) (Please see PAIR WEB site http://pair.uspto. gov for additional applicants):
`
`SENJU PHARMACEUTICAL CO., LTD., Osaka, JAPAN, Assignee (With 37 CFR 1.172 Interest);
`Shirou SAWA, Hyogo, JAPAN;
`Shuhei FUJITA, Hyogo, JAPAN;
`
`The United States represents the largest, most dynamic marketplace in the world and is an unparalleled location
`for business investment, innovation, and commercialization of new technologies. The USA offers tremendous
`resources and advantages for those who invest and manufacture goods here. Through SelectUSA, our nation
`works to encourage and facilitate business investment. To learn more about why the USA is the best country in
`the world to develop technology, manufacture products, and grow your business, visit SelectUSA.gov.
`
`Pa e 6 of 145
`IR103 (Rev.
`/09)
`
`Page 6 of 145
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Addiess. COMMISSIONER FOR PATENTS
`,. Box 1450
`xaJidria,Vi.1gLnia 22313-1450
`www.uspto.gov
`
`APPLICATION NUMBER
`
`F ING OR 371 (C) DATE
`
`FIRST NAMED APPLICANT
`
`ATTY. DOCKET NO./TITLE
`
`14/165,976
`
`01/28/2014
`
`Shirou SAWA
`
`2014-0075
`CONFIRMATION NO. 4523
`
`513
`
`WENDEROTH, LIND & PONACK, L.L.P.
`1030 15th Street, N.W.,
`Suite 400 East
`
`Washington, DC 20005-1503
`
`PUBLICATION NOTICE
`
`IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII IIIII IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII
`0000000685959 6
`
`Title:AQUEOUS LIQUID PREPARATION CONTAINING 2—AM|NO—3—(4—BROMOBENZOYL)PHENYLACETIC
`ACID
`
`Publication No.US—2014—0142183—A1
`Publication Date:05/22/2014
`
`NOTICE OF PUBLICATION OF APPLICATION
`
`The above-identified application will be electronically published as a patent application publication pursuant to 37
`CFR 1.211, et seq. The patent application publication number and publication date are set forth above.
`
`The publication may be accessed through the USPTO's publically available Searchable Databases via the
`Internet at www.uspto.gov. The direct link to access the publication is currently http://www.uspto.gov/patft/.
`
`The publication process established by the Office does not provide for mailing a copy of the publication to
`applicant. A copy of the publication may be obtained from the Office upon payment of the appropriate fee set forth
`in 37 CFR 1.19(a)(1). Orders for copies of patent application publications are handled by the USPTO's Office of
`Public Records. The Office of Public Records can be reached by telephone at (703) 308-9726 or (800) 972-6382,
`by facsimile at (703) 305-8759, by mail addressed to the United States Patent and Trademark Office, Office of
`Public Records, Alexandria, VA 22313-1450 or via the Internet.
`
`In addition, information on the status of the application, including the mailing date of Office actions and the
`dates of receipt of correspondence filed in the Office, may also be accessed via the Internet through the Patent
`Electronic Business Center at www.uspto.gov using the public side of the Patent Application Information and
`Retrieval (PAIR) system. The direct link to access this status information is currently http://pair.uspto.gov/. Prior to
`publication, such status information is confidential and may only be obtained by applicant using the private side of
`PAIR.
`
`Further assistance in electronically accessing the publication, or about PAIR, is available by calling the Patent
`Electronic Business Center at 1-866-217-9197.
`
`Office of Data Managmcnt, Application Assistance Unit (571) 272-4000, or (571) 272-4200, or 1-888-786-0101
`
`page 1 of 1
`
`Page 7 of 145
`
`Page 7 of 145
`
`
`
`
`
`PA RT ii ~ .l*7El4I{S} TEA NSM.IT'l‘A.L
`
`Cmnplete and send ihis fern}, mgether with étpplicalzie .l‘ee(s}, to:
`
`or
`
`Mail Stop ISSIEIEL FEE
`(.?t1n1n1iss.i0.:1e1' fur Patents
`RU. Buys: 1450
`Mexandria, Viuginia ;2:.’?.3i£ 3-1 -1517?
`(571)-273-2385
`
`fhtcmgix 5 shouid be cmnplcicd where
`l.‘>£~:n:'k.s. 1
`‘.1‘§1i,~*
`I
`iTo.:‘sn <.1u;-uE»;l Ens maxi fur u'anmnimn:z_ 1.11:‘. 15
`.1‘ Ff-iI::‘. and P1.3B1..IC.-'\’1‘It‘.)i\‘ X-*‘§E,‘:':i (if_m3ui;~;--d).
`‘J'RI?~=LT1‘I(ZI:
`‘G:
`
`
`
`
`
`
`
`
`1‘rmsk<d E5’: the, <:um'.~.r:i corr
`3n §.~F'§ zuvgl Jzmifim in of n.1;n'.n::‘mum;= 5
`,:zp§:r:_>;_>_r:.
`..
`-M ‘>l‘u:‘l1‘;-'.~‘
`emf:»..spoz':rlcz':;§s iL1ci.u»;‘ling' Iihv E
`.\\lUi. ;::h:;m
`~< viii
`Jssiiesscrg. a:‘1_:iv‘~<< as
`smicatcd xmi-3.5.3 ::os;'c:1cd h1:I»'3\=«= or dzm;'i.e:d 0t1‘n:rw1,s~. in rm-pg L by 6 :1} ‘Sf.‘ii;‘Ci§)'in}.‘,'
`:1. 112w o:.=r11:sponoI‘::m‘.«:‘. srdai:\;:;s: and.-"u;‘ {b} ind1c2:£1;;g_ 5: scyrnarzsia;
`- ADDRE:
`..
`his-r
`_«.1\aiutm1m\:%t‘ {ms am£§fic3‘Lim':s.
`—-
`1‘
`
`:33" mt
`17-‘: xased Em‘ d¢xm:s::§c mg:
`-fa c»-:néf‘§_c.2a:.:: of mz~.ii1'sas.5 L‘;-‘H1 cmh'
`
`
`}.‘tT
`1't{!etl1}"!flg
`t.>t.hE‘S' :1
`"1"Il1s.<. ct‘.:‘iifi
`lit‘ r.‘;'1.11imI hr: u5«.:‘¢i ff)
`
`
`ggmmzur my m;‘m.=:{ d;*.=n'\':,ng, must
`_ ‘
`:1: p.;;.\: ‘ ‘such as an
`gape I
`mw 115 own ::m‘E;iu:ext:~ oi‘ ;Jr..'5;iu1g, rsr Lm‘nsm1sss<:>1L
`
`
`
`
`
`
`ss maii 5'3; 311 e11V'el(up£r
`.
`f:u'.:x‘-irnd»':
`z:h:m':.
`1'14!
`ix-.‘;1\~2_‘
`_.
`.. U3’! ihe. ci:i:t€.311d\(::~11t‘.d bslow.
`
`
`
`
`V
`_
`_
`_
`_
`_
`
`r.‘:_-.::_‘.‘\t-NI um
`83‘ 2:1‘-‘r:-Kc: 9.»: :3!,.:-<5:
`
`_
`_
`:'x:q».1:4y (£m:3:: -):‘.\;:<h‘>:«3.\3
`
`s
`
`is
` : .:.=
`
`
`
`
`
`Di5{R(}'Fi;’i. i. IND Z:’()N
`I030 135?} Stmczt, N.W
`Suite. 490 E32251
`W:1shi:3gI(.»s1, §.){'.‘. ‘?.Ui{}{}5- £503
`
`:1e:~rrw«‘;
`
`
`
`('?:*Z'JN£iR:‘.~‘§.-\‘.E'§{T*:\‘N0.
`.-\.§’I3f..iC'I.=*C§.'§(FN Ni'.>.
`1*'II..ING"Efi.-\'IԤ.?
`:‘~FAf\~f".E'*l‘.-E.iN¥’E‘iN'§“'J1E%
`:\"E"l"€'I!.E{:\5E3Y3L}€'II('TKi§fE'N().
`‘
`M-."‘ 1 <$'3.,‘}‘3f>
`ill‘ 1;";'£%’=r‘;~‘;-TI} 4
`E‘«hir<.=Lt .‘:L~'\‘-7\".~'\
`211'! E -34)?
`-1533.
`‘1‘l1‘l..Ii 0}" \"E;\“5s‘§(.i.:\‘: sX[§7‘ ti ‘ THC .-“\Ii.7‘I§}
`
`D.-‘sf‘:‘i‘. Di
`
`
`
`OR t‘_".£'.‘i£_‘5;\‘-‘l‘R '1’)
`
`
`
`
`
`
`1ssuc.Fe.c.
`L.) Puh!ic.:xi.iun 155:9 (Ni: .=.1‘il11H -:‘m.§£'§-' (fm:o1:nt ;.n:rn1itts;-(13
`
`G Aria-‘;—mc& {.1n'1e.r - 3}‘ -.*';f'(‘.‘opi:\~;
`
`4b. Pa}~11‘wnt uI‘13'zt:‘£'.<}: {I-'11-:1sv.fi1.~at. rmppI}- may p‘rtwimIs!_s- pa.'td issue‘ an slluwn zsbm t‘)
`:1 A check: is e11c!osed,
`Pa}-‘rm-at Ea}-' cnrdit cam.'f‘\11‘m‘}‘*i°C)=fit?3T%‘is“31‘tsTc‘h‘ct'l‘.
`-
`:3 ' R‘.i.}l‘l
`:Q'l‘§n:1)ism-Luris; l1§1‘c:”s§-'{11sfl‘;u1'izmiIn 1,
`M-‘x‘::‘p;t§.-‘Jnc:x11_. to Dtposnt .-Mzcouui 3% mm
`
`'
`
`ll}: 3 irrdu-'s¢iu;:i
`
`{..r::po.z‘:1‘t1<.>JJ L31‘ mm»: prw;;:'
`
`£‘.iuv::mrnc:nI
`
`‘onyx m1m.y
`
`
`
`
`
`{,‘.h:m;;e in 3:-‘.l‘If.il§‘ Slmus ifmtu =,:£;55.L1'5 5mlin‘:s5.t'd zsbcgwi
`A.pp\i'»;2111£agcrtifivingsllicmcretii)‘ stature,
`3'3 CPR. 1.139
`
`G ;'\f.q'1§it'.:u3t 33-.::t'ri1s'sg .’:rr:::lI »':53LiL‘§~ .~:i:LL‘us. Sw 1'42? f.‘.H{ 1.3?‘
`,...
`
`\‘ (V.
`
`i‘?.v".‘\’}3fi.*?,=\ and 1.‘t‘=i‘i'},
`-'>.h:~'e.;.wt a valid ce:>tii‘1'c:‘.iior: -*af’§e-iicm I~.’.n1‘i£‘\_-‘
`-
`‘ wins if fork
`
`
`fer: p mem in the micm t‘mil'§= ::rm'.:sJ.m wiii mzrt int‘ 3.:
`zpiz‘:-£1 ::i U11‘ Us ui ¢I[J[.1§J"C£1{J'L‘:t1 almudmnm‘:-ni.
`:”~'£OTl’i: If tin: ::p;JIit=;xtiu11 was p:t*~:iu.1s.~'.l\- ‘Hm’!-;:::' :1m‘u:H:.nIiL3; $:.21Lus._ <.‘.I*si:.:.i;§ssg this box wiii be t.:'s.‘»-;.€n
`10 be ;n10iifiv;‘.=1IiL.‘r1l at‘ Ems 9E5i:uE§lh‘.111-2:11 in micro $n£l l‘_¢' suuus.
`Siut.\fi}igita||y signed by f_Tl1t‘ckj11g ilmis Ema wiii he l.~\i~'.:‘1\ in he :1m'>‘ri5ica1ion rs!" iusz r:5":‘.111ir¥s;rs1¢:ss£ L0 sntaii or mtc.1'r.~
`suing msus, as apf!ilt‘—£ihIt‘—..
`
`=.J Ap_plir:m1t c:I':m'¢;_>jng
`
`1
`
`'1‘ 213:‘ u..u.cl1st'm.:.u.L:“‘
`
`
`
`
`
`Aurfamiami $1‘g!1.'5‘I,Lkl‘&‘:
`
`“1"},~pmi nr ;,m"n fed :1.1rm: _ _ _ _
`
`_‘
`
`f{vg1'_\':1‘::I'ic_::.1 ;\:u_
`
`
`Page 8 of 145
`
`}"’::gae. 2 mi‘ 3
`
`1“"'E‘(Ti-I_.v85 Part B if ‘i8‘1E'} .—'\p;:mvcd far ms: z.E1s"c>ug'h iC>f.?~1.r'2{‘.*3 3.
`
`();\-’ii-} {)s’:'5lvOO33
`
`‘P-.u=::nE sand ’I‘mdsms:r}; (bfficur: 1.3.53‘. {TIE-3}‘,.<\Is’[I’M _\‘5'{‘ 01-’ CDZX-I-.\»
`
`
`
`‘ '
`
`5141-6133001)
`
`
`{ “'.‘}1;:s;§:=;: vi." ¢‘:0lTt‘1:p{Jm.Ei:5sL‘f: anlvlmczs m‘ im1'u‘;s5.'Lmx of "§>’m': .:\.:'§rJn‘as" 437'
`
`
`
`
`‘.3. F01‘ ;.I1i:1iir:g¢_:n the patent fro.-mi gsagzé. liar
`WENBEROTH UM) St WJNACK U _,,
`-
`,
`.
`.
`‘
`{IR 14.563).
`¢
`w
`{1} "H19 rm/rr_;:..s at‘ 11 ‘: 2;’:
`'4 1'¢:gi5:,m'c:¢i palm: aEic.::m‘),\s
`——————————————————————————————————————————————————————————————————~
`
`or agents (JR. ;;i1m'11s:Ein~
`sdcxzc-: 2u,Ex,Es":.:
`L.) ifizangc of cps;
`-
`~
`.
`,
`-
`.-
`.~-
`.~
`,
`,.
`_
`_
`E221,‘ mimxtmd.
`.:k.ddn>:s.~“; EEJIII1 I-“
`H1, gmfng Q} 3 gjgjgig{1f1n‘kfg,5§.u\Q
`11 ;3_u;';_Ҥ_}.3j_ 3
`I
`1.: and Sim zmmes oi‘ up to
`‘
`Micim ‘ In "
`‘am-£n:m1.~;:;: in
`=
`
`
`:3
`‘m_ _ ‘s c-1‘:x_<.;.r.-1:15.’. ii no name‘ 18
`= (333.2 ms‘ m-.-m‘ 5
`iii) aEr:u':E‘1c(i.
`’
`_ .«':
`.
`H’
`"""""""""""""""""""""""""""""""""" "
`iflmii-‘=1
`Nnmlaer I.‘-I requin*.ri.
`
`'\?\-Hi .fiLND R£iSll‘.IKi3~'CI£ DA‘ '
`
`
`
`I!’ an aasignur Ea itk‘.1!(ifit‘i_i bcirjw. the «.11»-_'s.x.:\‘\»:‘;\1 §s:1.<. §Jt'1;ss fiied fuzzy‘
`‘ed bc‘:ms-g my :m‘§g1,\c_\-‘ qaia \'.~‘j.H> z:;.I;.It;:11' gm the misfit
`Ejcle
`5.?5:51:35 an . gigrgcc‘
`
`. R 3.1!, 3m 5. xsuouot thm iorm1s;N()“i':1subsmu£s ti.r1't1img an;
`gjusilmaz.
`IL: ((’.'l'l":.’ and 5 2:3.
`1
`
`
`.5 a‘_r;-an
`
`i
`
`7
`-—................................................................. ..
`
`
`
`:'fr*-5" (_‘.has1gc of C '):‘i"C§}§iw'1I1i,i\;“I1€t
`
`
`
`
`
`Page 8 of 145
`
`
`
`Electronic Patent Application Fee Transmittal
`
`T'tIe °f I'“’e"t'°"‘
`
`AQUEOUS LIQUID PREPARATION CONTAINING 2-AM|NO-3-(4-
`BROMOBENZOYL)PHENYLACETIC ACID
`
`;
`
`Utility under 35 USC111(a) Filing Fees
`
`Description
`
`Fee Code
`
`Quantity
`
`Sub-Total in
`
`USD($)
`
`Basic Filing:
`
`Miscellaneous-Filing:
`
`Patent-Appeals-and-Interference:
`
`Post-AlIowance-and-Post-Issuance:
`
`EX*e"sI»°ag-e°5-Ems
`
`Page 9 of 145
`
`
`
`Miscellaneous:
`
` S“:-S1-;(t$a)| in
`
`Total in USD (S)
`
`Page 10of145
`
`Page 10 of 145
`
`
`
`Electronic Acknowledgement Receipt
`
`m—
`
`T'tIe °f I'“'e"t'°"‘
`
`AQUEOUS LIQUID PREPARATION CONTAINING 2-AM|NO-3-(4-
`BROMOBENZOYL)PHENYLACETIC ACID
`
`I
`
`Payment information:
`
`yes—
`Submitted with Payment
`
`filagrgq qqyfldrgitional Fees required under 37 C.F.R. Section 1.17 (Patent application and reexamination processing fees)
`
`—Authorized User
`The Director of the USPTO is hereby authorized to charge indicated fees and credit any overpayment as follows:
`
`CHEEKJR., WARREN M.
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.16 (National application filing, search, and examination fees)
`
`Page 11 of 145
`
`
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.19 (Document supply fees)
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.20 (Post Issuance fees)
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.21 (Miscellaneous fees and charges)
`
`File Listing:
`
`Document
`
`.
`
`.
`
`File Size(Bytes)/
`
`Multi
`
`Pages
`
`Issue Fee Payment (PTO-85B)
`
`AttachA_|F.pdf
`
`418761
`
`367b87c3f74ec7e02944d8e849d91 c93e3e
`6cc09
`
`The PDF file has been signed with a digital signature and the legal effect of the document will be based on the contents of the file not the
`digital signature.
`
`Fee Worksheet (SB06)
`
`fee-info.pdf
`
`b9767fed8cc5cf295f86eae8ec66cb5fe5e9b
`106
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO ofthe indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`New Applications Under 35 U.S.C. 111
`lfa new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`1.53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date of the application.
`
`National Stage of an International Application under 35 U.S.C. 371
`lfa timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/E0/903 indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`
`New International Application Filed with the USPTO as a Receiving Office
`lfa new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the International Application Number
`and ofthe International Filing Date (Form PCT/R0/105) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`the application.
`
`Page 12 of145
`
`Page 12 of 145
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`www.uspto.gov
`
`NOTICE OF ALLOWANCE AND FEE(S) DUE
`
`513
`
`7590
`
`04/21/2014
`
`WENDEROTH, LIND & PONACK, L.L.P.
`1030 15th Street, N.W.,
`suite 400 East
`Washington, DC 20005-1503
`
`soRoUsH,LAYLA
`
`1527
`
`DATE MAILED: 04/21/2014
`
`14/165,976
`
`01/28/2014
`
`Shirou sAwA
`
`2014-0075
`
`4523
`
`TITLE OF INVENTION: AQUEOUS LIQUID PREPARATION CONTAINING 2—AMINO—3-(4—BROMOBENZOYL)PHENYLACETIC ACID
`
`APPLN. TYPE
`
`ENTITY STATUS
`
`ISSUE FEE DUE
`
`PUBLICATION FEE DUE
`
`PREV. PAID ISSUE FEE
`
`TOTAL FEE(S) DUE
`
`DATE DUE
`
`nonprovisional
`
`UNDISCOUNTED
`
`$960
`
`$0
`
`$0
`
`$960
`
`07/21/2014
`
`THE APPLICATION IDENTIFIED ABOVE HAS BEEN EXAMINED AND IS ALLOWED FOR ISSUANCE AS A PATENT.
`PROSECUTION ON THE MERITS IS CLOSED. THIS NOTICE OF ALLOWANCE IS NOT A GRANT OF PATENT RIGHTS.
`THIS APPLICATION IS SUBJECT TO WITHDRAWAL FROM ISSUE AT THE INITIATIVE OF THE OFFICE OR UPON
`PETITION BY THE APPLICANT. SEE 37 CFR 1.313 AND MPEP 1308.
`
`THE ISSUE FEE AND PUBLICATION FEE (IF REQUIRED) MUST BE PAID WITHIN THREE MONTHS FROM THE
`MAILING DATE OF THIS NOTICE OR THIS APPLICATION SHALL BE REGARDED AS ABANDONED.
`THIS
`STATUTORY PERIOD CANNOT BE EXTENDED.
`SEE 35 U.S.C. 151. THE ISSUE FEE DUE INDICATED ABOVE DOES
`NOT REFLECT A CREDIT FOR ANY PREVIOUSLY PAID ISSUE FEE IN THIS APPLICATION.
`IF AN ISSUE FEE HAS
`PREVIOUSLY BEEN PAID IN THIS APPLICATION (AS SHOWN ABOVE), THE RETURN OF PART B OF THIS FORM
`WILL BE CONSIDERED A REQUEST TO REAPPLY THE PREVIOUSLY PAID ISSUE FEE TOWARD THE ISSUE FEE NOW
`DUE.
`
`HOW TO REPLY TO THIS NOTICE:
`
`I. Review the ENTITY STATUS shown above. If the ENTITY STATUS is shown as SMALL or MICRO, verify Whether entitlement to that
`entity status still applies.
`
`If the ENTITY STATUS is the same as shown above, pay the TOTAL FEE(S) DUE shown above.
`
`If the ENTITY STATUS is changed from that shown above, on PART B - FEE(S) TRANSMITTAL, complete section number 5 titled
`"Change in Entity Status (from status indicated above)".
`
`For purposes of this notice, small entity fees are 1/2 the amount of undiscounted fees, and micro entity fees are 1/2 the amount of small entity
`fees.
`
`II. PART B - FEE(S) TRANSMITTAL, or its equivalent, must be completed and returned to the United States Patent and Trademark Office
`(USPTO) with your ISSUE FEE and PUBLICATION FEE (if required). If you are charging the fee(s) to your deposit account, section "4b"
`of Part B - Fee(s) Transmittal should be completed and an extra copy of the form should be submitted. If an equivalent of Part B is filed, a
`request to reapply a previously paid issue fee must be clearly made, and delays in processing may occur due to the difficulty in recognizing
`the paper as an equivalent of Part B.
`
`III. All communications regarding this application must give the application number. Please direct all communications prior to issuance to
`Mail Stop ISSUE FEE unless advised to the contrary.
`
`IMPORTANT REMINDER: Utility patents issuing on applications filed on or after Dec. 12, 1980 may require payment of
`maintenance fees. It is patentee's responsibility to ensure timely payment of maintenance fees when due.
`
`Page 13 of 145
`PTOL—85 (Rev. 02/11)
`
`Pag°1°f3
`
`Page 13 of 145
`
`
`
`PART B - FEE(S) TRANSMITTAL
`
`Complete and send this form, together with applicable fee(s), to: Mail Mail Stop ISSUE FEE
`Commissioner for Patents
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`or 1 (571)-273-2885
`
`through 5 should be completed where
`INSTRUCTIONS: This form should be used for transmitting the ISSUE FEE and PUBLICATION FEE (if required). Blocks 1
`appropriate. All further correspondence including the Patent, advance orders and notification of maintenance fees will be mailed to the current correspondence address as
`in icated unless corrected below or directed otherwise in Block 1, by (a) specifying a new correspondence address; and/or (b) indicating a separate "FEE ADDRESS" for
`maintenance fee notifications.
`
`CURRENT CORRESPONDENCE ADDRESS (Note: Use Block 1 for any Change Ofaddress)
`
`7590
`513
`WENDEROTH, LIND &
`1030 15th Street N W
`_
`Suite 400 East
`
`Washington, DC 20005-1503
`
`04/21/2014
`
`Note: A certificate of mailin can only be used for domestic mailings of the
`Fee(s) Transmittal. This certi icate cannot be used for any other accompanying
`fiapers. Each additional paper, such as an assignment or formal drawing, must
`ave its own certificate of mailing or transmission.
`
`Certificate of Mailing or Transmission
`I hereby certify that this Fee(s) Transmittal is being deposited with the United
`States Postal Service with sufficient postage for first class mail in an envelope
`addressed to the Mail Stop ISSUE FEE address above, or being facsimile
`transmitted to the USPTO (571) 273-2885, on the date indicated below.
`
`(Date)
`
`(Depositorvsname)
`(Signature)
`
`APPLICATION NO.
`
`FILING DATE
`
`F {ST NAMED INVENTOR
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`14/165,976
`
`01/28/2014
`
`Shirou SAWA
`
`2014-0075
`
`4523
`
`TITLE OF INVENTION: AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID
`
`APPLN. TYPE
`
`ENTITY STATUS
`
`ISSUE FEE DUE
`
`PUBLICATION FEE DUE
`
`PREV. PAID ISSUE FEE
`
`TOTAL FEE(S) DUE
`
`DATE DUE
`
`nonprovisional
`
`UNDISCOUNTED
`
`SOROUSH, LAYLA
`
`$960
`
`1627
`
`$0
`
`$0
`
`$960
`
`07/21/2014
`
`514-619000
`
`1. Change of correspondence address or indication of "Fee Address" (37
`CFR 1.363).
`
`3 Chan e of correspondence address (or Change of Correspondence
`Address orm PTO/SB/ 122) attached.
`
`3 "Fee Address" indication (or "Fee Address" Indication form
`PTO/SB/47; Rev 03-02 or more recent) attached. Use of a Customer
`Vumber is required.
`
`
`
`2. For printing on the patent front page, list
`(1) The names of up to 3 registered patent attorneys
`or agents OR, alternatively,
`(2) The name of a single firm (having as a member a
`registered attorney or agent) and the names of up to
`2 registered patent attorneys or agents. If no name is
`listed, no name will be printed.
`
`2
`
`3
`
`3. ASSIGNEE NAME AND RESIDENCE DATA TO BE PRINTED ON THE PATENT (print or type)
`If an assignee is identified below, the document has been filed for
`PLEASE NOTE: Unless an assignee is identified below, no assignee data will appear on the patent.
`recordation as set forth in 37 CFR 3.11. Completion of this form is NOT a substitute for filing an assignment.
`(A) NAME OF ASSIGNEE
`(B) RESIDENCE: (CITY and STATE OR COUNTRY)
`
`Please check the appropriate assignee category or categories (will not be printed on the patent) :
`
`'3 Individual
`
`'3 Corporation or other private group entity '3 Government
`
`4a. The following fee(s) are submitted:
`3 Issue Fee
`
`4b. Payment of Fee(s): (Please first reapply any previously paid issue fee shown above)
`3 A check is enclosed.
`
`3 Publication Fee (No small entity discount permitted)
`3 Advance Order — # of Copies
`
`3 Payment by credit card. Form PTO-2038 is attached.
`3 The Director is hereby authorized to charge the required fee(s), any deficiency, or credits any
`overpayment, to Deposit Account Number
`(enclose an extra copy of this form).
`
`5. Change in Entity Status (from status indicated above)
`3 Applicant certifying micro entity status. See 37 CFR 1.29
`
`3 Applicant asserting small entity status. See 37 CFR 1.27
`
`3 Applicant changing to regular undiscounted fee status.
`
`\IOTE: Absent a valid certification of Micro Entity Status (see forms PTO/SB/ 15A and 15B), issue
`fee payment in the micro entity amount will not be accepted at the risk of application abandonment.
`\IOTE: If the application was previously under micro entity status, checking this box will be taken
`to be a notification of loss of entitlement to micro entity status.
`\IOTE: Checking this box will be taken to be a notification of loss of entitlement to small or micro
`entity status, as applicable.
`
`NOTE: This form must be signed in accordance with 37 CFR 1.31 and 1.33. See 37 CFR 1.4 for signature requirements and certifications.
`
`Authorized Signature
`
`Typed or printed name
`
`Date
`
`Registration No.
`
`Page 14 of 145
`
`Page 2 of 3
`
`PTOL-85 Part B (10-13) Approved for use through 10/31/2013.
`
`OMB 0651-0033
`
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`
`Page 14 of 145
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`www.uspto.goV
`
`APPLICATION NO.
`
`FILING DATE
`
`F {ST NAMED INVENTOR
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`14/165,976
`
`01/2s/2014
`
`Shirou sAwA
`
`2014-0075
`
`4523
`
`WENDEROTH, LIND & PONACK, L.L.P.
`1030 15th Street, N.W.,
`Suite 400 East
`Washington, DC 20005-1503
`
`soRoUsH,LAYLA
`
`1527
`
`DATE MAILED: 04/21/2014
`
`Determination of Patent Term Adjustment under 35 U.S.C. 154 (b)
`
`(application filed on or after May 29, 2000)
`
`The Patent Term Adjustment to date is 0 day(s). If the issue fee is paid on the date that is three months after the
`mailing date of this notice and the patent issues on the Tuesday before the date that is 28 weeks (six and a half
`months) after the mailing date of this notice, the Patent Term Adjustment will be 0 day(s).
`
`If a Continued Prosecution Application (CPA) was filed in the aboVe—identified application, the filing date that
`determines Patent Term Adjustment is the filing date of the most recent CPA.
`
`Applicant will be able to obtain more detailed information by accessing the Patent Application Information Retrieval
`(PAIR) WEB site (http://pair.uspto.goV).
`
`Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the Office of
`Patent Legal Administration at (571)-272-7702. Questions relating to issue and publication fee payments should be
`directed to the Customer Service Center of the Office of Patent Publication at 1—(888)—786—0101 or (571)-272-4200.
`
`Page 15 of 145
`PTOL—85 (Rev. 02/11)
`
`Page 3 °f 3
`
`Page 15 of 145
`
`
`
`OMB Clearance and PRA Burden Statement for PTOL-85 Part B
`
`The Paperwork Reduction Act (PRA) of 1995 requires Federal agencies to obtain Office of Management and
`Budget approval before requesting most types of information from the public. When OMB approves an agency
`request to collect information from the public, OMB (i) provides a valid OMB Control Number and expiration
`date for the agency to display on the instrument that will be used to collect the information and (ii) requires the
`agency to inform the public about the OMB Control Number’s legal significance in accordance with 5 CFR
`1320.5(b).
`
`The information collected by PTOL-85 Part B is required by 37 CFR 1.311. The information is required to obtain
`or retain a benefit by the public which is to file (and by the USPTO to process) an application. Confidentiality is
`governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 12 minutes to complete,
`including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary
`depending upon the individual case. Any comments on the amount of time you require to complete this form
`and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, Virginia 22313-1450. DO NOT
`SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box
`1450, Alexandria, Virginia 22313-1450. Under the Paperwork Reduction Act of 1995, no persons are required to
`respond to a collection of information unless it displays a valid OMB control number.
`
`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection witl1 your
`submission of the attached form related to a patent application or patent. Accordingly, pursua